Detail akcie China Pharm online

Business Summary: CSPC Pharmaceutical Group Limited is an investment holding company principally engaged in the manufacture and sales of pharmaceutical products. The Company sells its products under the brand of CSPS. The Company has four business segments: Finished Drugs, Antibiotics (intermediates and bulk drugs), Vitamin C (bulk drugs) and Caffeine and Others (bulk drugs). All these segments are engaged in the manufacture and sales of related pharmaceutical products. The finished drugs include the antibiotics, cardio-cerebrovascular drugs, diabetes drugs, neurology drugs, oncology drugs and traditional Chinese medicines. The Company is also engaged in the provision of pharmaceutical research and development services, as well as the processing of sewage and pharmaceutical by-products through its subsidiaries.
Financial Summary: BRIEF: For the three months ended 31 March 2026, CSPC Pharmaceutical Group Ltd revenues decreased 8% to RMB6.47B. Net income decreased 42% to RMB859.8M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income also reflects Research and development expenses increase of 8% to RMB1.4B (expense), Other gains or losses decrease of 66% to RMB45.9M (income).